Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.

Fulcher, Gregory R; Akhtar, Shahid; Al-Jaser, Saleh J; Medina, Johan; Mohamed, Mafauzy; Nicodemus, Nemencio A; Olsen, Anne Helene; Singh, Kiran P; Kok, Adri

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.

Fulcher, Gregory R; Akhtar, Shahid; Al-Jaser, Saleh J; Medina, Johan; Mohamed, Mafauzy; Nicodemus, Nemencio A; Olsen, Anne Helene; Singh, Kiran P; Kok, Adri.

Afiliación

Fulcher GR; Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, Sydney, NSW, 2065, Australia. greg.fulcher@sydney.edu.au.
Akhtar S; Northern Clinical School, University of Sydney, Sydney, NSW, Australia. greg.fulcher@sydney.edu.au.
Al-Jaser SJ; Novo Nordisk Region Asia Pacific, Dubai, United Arab Emirates.
Medina J; Department of Internal Medicine, Specialized Medical Center Hospital, Riyadh, Saudi Arabia.
Mohamed M; Novo Nordisk A/S, Søborg, Denmark.
Nicodemus NA; Department of Medicine, Hospital Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Olsen AH; Department of Biochemistry and Molecular Biology, University of the Philippines-College of Medicine, Manila, Philippines.
Singh KP; Novo Nordisk A/S, Søborg, Denmark.
Kok A; Department of Endocrinology, Fortis Hospital, Mohali, Punjab, India.

Adv Ther ; 40(1): 389-390, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36315342

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google